EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudieOpen Access · CC BY 4.0

COVID‐19 Vaccination and the Risk of Migraine Chronification: A Comparative Cohort Study of Vaccinated and Unvaccinated Patients With Episodic Migraine

Mostafa Meshref iD, Hossam Younis iD, Khabab Abbasher Hussien Mohamed Ahmed iD, Elsayed Abed iD, Abdallah Abbas iD, Yehia Nabil iD, Abdullah Ashraf Hamad iD, Muhammad Atallah Gad, Nour Shaheen iD, Mahmoud Farid Abdelmonem, Ahmed Gaballa, Ahmed Kohail und 4 weitere

Brain and Behavior · 2026-11 · 16 (11)

DOI: 10.1002/brb3.71881 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Brain and Behavior, online erschienen am 30.10.2026. Verfasst von Mostafa Meshref und 15 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt. Hauptthemen laut MEDLINE: Migraine Disorders, COVID-19, Vaccination, COVID-19 Vaccines. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Headache is among the most frequently reported adverse events after COVID‐19 vaccination, and patients with migraine often fear that vaccination will worsen their disease or accelerate the transition from episodic to chronic migraine. Controlled data comparing vaccinated and unvaccinated patients with migraine are scarce.

Methods

We conducted a comparative prospective cohort study of 60 adults with pre‐existing episodic migraine, classified at enrolment as vaccinated ( n = 30) or unvaccinated ( n = 30) against COVID‐19, at a single neuroscience clinic in Jeddah, Saudi Arabia, and followed for 6 months. Migraine status (episodic or chronic, per ICHD‐3) was assessed at 3 and 6 months. Between‐group chronification was compared using Fisher's exact test with odds ratios (ORs) and 95% confidence intervals (CIs); patient‐level transitions were also examined. No a priori sample‐size calculation was performed.

Results

There were no statistically significant baseline differences between groups in age (30.3 ± 5.07 vs. 30.5 ± 4.46 years; p = 0.87), sex ( p = 0.78), or preventive medication ( p = 0.58). Provisional chronic‐frequency status was recorded in 5/30 vaccinated versus 11/30 unvaccinated patients at 3 months (OR 0.35, 95% CI 0.10–1.16; p = 0.14), and chronic migraine in 3/30 versus 6/30 at 6 months (OR 0.44, 95% CI 0.10–1.97; p = 0.47). All such transitions occurred by 3 months, with no new cases between 3 and 6 months; the confidence intervals were wide and included no difference.

Conclusions

In this small observational cohort, no statistically significant association was detected between COVID‐19 vaccination and migraine chronification. The wide confidence intervals preclude firm conclusions regarding either harm or benefit, and larger, adequately powered studies are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersCOVID-19VaccinationCOVID-19 VaccinesHumansMaleFemaleAdultUnvaccinated PersonsProspective StudiesCohort StudiesChronic DiseaseSaudi ArabiaYoung Adult

Stichwörter der Autor:innen

COVID‐19 vaccinationcohort studyepisodic migrainemigraine chronification

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Neurology Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
  • Neuroscience Department, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia.
  • Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
  • Department of Pathophysiology, School of Medicine, St. George's University, St. George's, Grenada, West Indies.
  • Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
  • Faculty of Medicine, Zagazig University, Zagazig, Egypt.

ORCID-Profile: Mostafa Meshref, Hossam Younis, Khabab Abbasher Hussien Mohamed Ahmed, Elsayed Abed, Abdallah Abbas, Yehia Nabil, Abdullah Ashraf Hamad, Nour Shaheen, Abdelrahman R Youssef, Khaled Moghib

Zitieren

APA

Meshref, M., Younis, H., Ahmed, K. A. H. M., Abed, E., Abbas, A., Nabil, Y., Hamad, A. A., Gad, M. A., Shaheen, N., Abdelmonem, M. F., Gaballa, A., Kohail, A., Ahmed, M. M., Ali, A. A., Youssef, A. R., & Moghib, K. (2026). COVID‐19 Vaccination and the Risk of Migraine Chronification: A Comparative Cohort Study of Vaccinated and Unvaccinated Patients With Episodic Migraine. Brain and Behavior, 16(11). https://doi.org/10.1002/brb3.71881

Vancouver

Meshref M, Younis H, Ahmed KAHM, Abed E, Abbas A, Nabil Y, et al. COVID‐19 Vaccination and the Risk of Migraine Chronification: A Comparative Cohort Study of Vaccinated and Unvaccinated Patients With Episodic Migraine. Brain and Behavior. 2026;16(11). doi:10.1002/brb3.71881

BibTeX
@article{Meshref2026,
  author = {Meshref, Mostafa and Younis, Hossam and Ahmed, Khabab Abbasher Hussien Mohamed and Abed, Elsayed and Abbas, Abdallah and Nabil, Yehia and Hamad, Abdullah Ashraf and Gad, Muhammad Atallah and Shaheen, Nour and Abdelmonem, Mahmoud Farid and Gaballa, Ahmed and Kohail, Ahmed and Ahmed, Mohamed Mahmoud and Ali, Abdelsalam Abdullah and Youssef, Abdelrahman R and Moghib, Khaled},
  title = {COVID‐19 Vaccination and the Risk of Migraine Chronification: A Comparative Cohort Study of Vaccinated and Unvaccinated Patients With Episodic Migraine},
  journal = {Brain and Behavior},
  year = {2026},
  volume = {16},
  number = {11},
  doi = {10.1002/brb3.71881}
}
Kostenlos starten →